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Cutaneous mechanosensory neurons detect me-
chanical stimuli that generate touch and pain sensa-
tion. Although opioids are generally associated only
with the control of pain, herewe report that the opioid
system in fact broadly regulates cutaneous mecha-
nosensation, including touch. This function is pre-
dominantly subserved by the delta opioid receptor
(DOR), which is expressed by myelinated mecha-
noreceptors that form Meissner corpuscles, Merkel
cell-neurite complexes, and circumferential hair
follicle endings. These afferents also include a small
population of CGRP-expressing myelinated noci-
ceptors that we now identify as the somatosensory
neurons that coexpress mu and delta opioid recep-
tors. We further demonstrate that DOR activation at
the central terminals of myelinated mechanorecep-
tors depresses synaptic input to the spinal dorsal
horn, via the inhibition of voltage-gated calcium
channels. Collectively our results uncover a molec-
ular mechanism by which opioids modulate cuta-
neous mechanosensation and provide a rationale
for targeting DOR to alleviate injury-induced me-
chanical hypersensitivity.
INTRODUCTION
The cutaneous mechanosensory system is critical for the detec-
tion and discrimination of innocuous and noxious mechanical1312 Neuron 81, 1312–1327, March 19, 2014 ª2014 Elsevier Inc.stimuli that elicit sensations of touch and pain, respectively
(Basbaum et al., 2009; Delmas et al., 2011; Lewin and Mosh-
ourab, 2004). However, innocuous stimuli in the setting of
injury can also evoke pain. Indeed, skin hypersensitivity to light
mechanical stimuli (also called mechanical allodynia or touch-
evoked pain) is one of the most common and distressing symp-
toms of nerve injury-induced neuropathic pain (Costigan et al.,
2009).
Of particular importance is the identification of the primary
sensory neurons of the dorsal root ganglion (DRG) that mediate
mechanical allodynia. We and others have shown that ablation
or silencing of several populations of unmyelinated nociceptors
(C fibers) does not alter nerve injury-induced mechanical
hypersensitivity in rodents (Abrahamsen et al., 2008; Cava-
naugh et al., 2009; Scherrer et al., 2010). By contrast, selective
compression block of myelinated axons (A fibers), which elimi-
nates the normal sense of touch while preserving C fiber func-
tion, abolishes touch-evoked neuropathic pain in humans
(Campbell et al., 1988). Electrophysiological studies demon-
strate that pharmacological disinhibition of spinal cord circuits
or peripheral injuries that cause mechanical hypersensitivity
strengthen Ab and Ad fiber input to nociceptive lamina I spinal
neurons, uncovering a mechanism by which activation of low-
threshold A fibers by normally innocuous mechanical stimuli
can cause pain (Torsney, 2011; Torsney and MacDermott,
2006). Together these results indicate that cutaneous mechano-
sensitive A fibers contribute to touch-evoked pain and that
drugs that dampen the function of these neurons might be an
effective treatment.
Delta, kappa, and mu opioid receptors (DOR, KOR, and
MOR, respectively) are G protein-coupled receptors that regu-
late neurotransmission, including at the level of primary afferent
DRG neurons (Williams et al., 2001). Opioids that preferentially
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Delta Opioid Receptors and Mechanosensory Neuronsactivate MORs (e.g., morphine, oxycodone, and fentanyl) are
widely used to treat severe pain, but their efficacy in chronic
neuropathic pain is subject to considerable uncertainty
(McNicol et al., 2013). A better understanding of the neural cir-
cuits and molecular mechanisms underlying opioid analgesia is
necessary for a more rational use of opioids in the clinic.
The expression pattern of DOR in DRG remains a subject of
substantial controversy. We recently showed that DOR is pre-
dominantly expressed by DRG neurons with myelinated axons
(Scherrer et al., 2009). Furthermore, DOR-selective agonists
display anti-allodynic properties in murine models of touch-
evoked neuropathic and inflammatory pain, and DOR null mice
exhibit increased mechanical hypersensitivity after peripheral
injury (reviewed in Gave´riaux-Ruff and Kieffer, 2011; Ossipov
et al., 2004). These findings suggested that DOR may be
expressed by cutaneous mechanosensory A fibers and that
DOR-mediated regulation of these afferents could counteract
nerve injury-associated mechanical hypersensitivity.
With the recent discovery that functionally distinct classes of A
fibers depend on distinct neurotrophins for their development
and survival, it is now possible to test this hypothesis. Thus,
cutaneous Ab low-threshold mechanoreceptors (LTMRs) ex-
press the neurotrophin receptors TrkC and/or Ret (Bourane
et al., 2009; Fu¨nfschilling et al., 2004; Li et al., 2011; Luo et al.,
2009; Senzaki et al., 2010), while Ad D-hair LTMRs express
TrkB (Li et al., 2011; Stucky et al., 1998). This molecular charac-
terization distinguishes touch-encoding cutaneous A fibers from
myelinated nociceptors, which most often express TrkA (Fang
et al., 2005) and the neuropeptide CGRP (Lawson et al., 2008),
and from proprioceptors that coexpress parvalbumin, TrkC,
and the transcription factor Runx3 (de Nooij et al., 2013).
Building on the ability to classify subpopulations of myelinated
afferents, here we conducted a neuroanatomical and electro-
physiological analysis to resolve the functional organization of
opioid receptors in DRG.
RESULTS
DORGFP Knockin Mouse Faithfully Reports DOR
Distribution in DRG and CNS
We previously used a DORGFP knockin mouse (Scherrer et al.,
2006) to establish the expression pattern of DOR in DRG (Scher-
rer et al., 2009). Most DORGFP+ DRG neurons have large-diam-
eter cell bodies and express the marker of myelinated affer-
ents neurofilament 200 (NF200) (67% of DORGFP+ cells are
NF200+) (Figures 1A and 1F; Table S1 available online). DORGFP
is expressed by 27%of all NF200+DRG neurons. Themajority of
DORGFP+ NF200 cells bind the isolectin B4 (IB4) (91% IB4+),
and 19% of IB4+ cells express DORGFP (Figures 1F and S1A;
Table S1), indicating that DOR+ small-diameter neurons
comprise a subset of nonpeptidergic C nociceptors. Accord-
ingly, very few DORGFP+ NF200 cells express substance P
(SP) (5%), and only about 2% of SP+ neurons express
DORGFP (Figures 1F and S1B; Table S1).
This DORGFP expression differs drastically from the immu-
noreactivity (ir) pattern generated in wild-type mice by an anti-
body that purportedly recognizes the N-terminal domain of the
receptor (anti-DOR3-17). DOR-ir was observed in a larger cellpopulation (about half of DRG neurons), mainly of small diam-
eter (Bao et al., 2003; He et al., 2011; Wang et al., 2010).
Furthermore, DOR-ir was always found to colocalize with SP
in peptidergic C nociceptors, an essential requirement for a
SP-DOR direct interaction that was proposed to sort DOR in
large dense-core vesicles and regulate its surface expression
(Guan et al., 2005). In situ hybridization studies performed
by the same group suggested that Oprd1 mRNA, which en-
codes DOR, might be present in 71% of small-diameter DRG
neurons.
To address this controversy, we took advantage of the recent
development of an ultrasensitive and specific method to detect
single mRNAmolecules in tissues (QuantiGene ViewRNA, Pano-
mics). We found that in DRG from wild-type mice, Oprd1mRNA
is concentrated in large-diameter neurons that express NF200
(Figures 1B, 1F, S1C, and S1D). These DRG cells often contain
hundreds of labeled dots in their cytoplasm. Thus, 62% of
DRG neurons with Oprd1 mRNA are NF200+. We then asked
whether the small-diameter, NF200 DRG neurons that express
Oprd1 mRNA belong to the peptidergic or nonpeptidergic class
of C nociceptors. We found that among 219 SP+ profiles exam-
ined, 204 did not contain a single labeled dot. Only 3 out of 219
cells displayed 5 or more labeled dots in their cytoplasm and
were considered positive (2%; Figures 1F and S1E), while 12
had only 1 or 2 dots, which was comparable to the background
level. Only about 2%of NF200DRGneuronswithOprd1mRNA
express SP, while the great majority (82%) of these cells bound
IB4 (Figures 1D–1F).
We next compared the DORGFP fluorescence pattern in the
CNS to the binding pattern of selective DOR radioligands, [3H]-
Deltorphin II and [3H]-DPDPE, in wild-type mice. We observed
that DORGFP distribution is strikingly similar to the binding
pattern of both DOR radioligands throughout the CNS. Thus,
DORGFP fluorescence and radioligand binding are particularly
intense in basolateral amygdala, striatum, cortex, pontine nu-
cleus, olfactory bulb, and olfactory tubercle (Figure 1G). In the
spinal cord, both DORGFP fluorescence and radioligand bind-
ing are seen throughout the gray matter (Figure 1H). This distri-
bution pattern differs profoundly from that generated by the
anti-DOR3-17 antibody, which labels exclusively the terminals
of peptidergic afferents in superficial dorsal horn (Guan et al.,
2005). Finally, note that binding of radioligands is lost in tissues
from Oprd1 knockout mice, demonstrating the specificity of
DOR labeling and localization (Figure 1G).
We conclude that the remarkably high correspondence
between the DORGFP distribution pattern and that of Oprd1
mRNA and DOR protein in wild-type mouse, which is consistent
with previous studies (Cahill et al., 2001; Goody et al., 2002;
Mansour et al., 1987, 1994; Mennicken et al., 2003; Minami
et al., 1995), argues very strongly that DORGFP expression
faithfully recapitulates that of native DOR.
TrkA, TrkC, and Ret Coexpression Reveals that DOR+
NF200+ Neurons Are Heterogeneous and Include
Nociceptors and LTMRs
We next resolved the molecular identity of DORGFP+ NF200+
neurons using a host of markers that define DRG neuron
subpopulations. Opioid receptor-expressing DRG neurons areNeuron 81, 1312–1327, March 19, 2014 ª2014 Elsevier Inc. 1313
Figure 1. DORGFPMouse Faithfully Reports DOR Expression in CNS and DRG, where DOR Is Predominantly Expressed by Large-Diameter,
Myelinated Neurons
(A) Costaining with anti-GFP and -NF200 antibodies shows that 67% of DORGFP+ DRG neurons express the marker of myelinated neurons NF200.
(B) Oprd1 mRNA is also predominantly present in NF200+ neurons in DRG from wild-type mice.
(C) Control showing that in the absence of the specific probe against Oprd1 sequence, there is no in situ hybridization signal in DRG neurons.
(D) Substance P+ (SP+) cells almost never contain Oprd1 mRNA in DRG neurons from wild-type mice.
(E) The great majority of NF200 cells that contain Oprd1 mRNA bind the isolectin B4 (IB4).
(F) Quantification of (A)–(E) and of Figures S1A and S1B. Left: neurons that coexpress DOR among those that express SP, or bind IB4, or express NF200. Right:
DOR+ neurons that coexpress NF200, and DOR+ NF200 neurons that coexpress SP or bind IB4.
(G) The distribution of fluorescence in brain slices from DORGFPmice is identical to the binding pattern of DOR radioligands [3H]-Deltorphin II and [3H]-DPDPE in
wild-type mice. Radiolabeling is lost in Oprd1 null mice, demonstrating specificity.
(H) In wild-type mouse spinal cord, [3H]-Deltorphin II binds to DORs that are present throughout the gray matter, consistent with DORGFP fluorescence pattern.
Data are represented as means ± SEM. Scale bars represent 50 mm. See also Figure S1.
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dynic properties of DOR agonists, we hypothesized that DOR+
DRG neurons could include LTMRs. Consistently, we found1314 Neuron 81, 1312–1327, March 19, 2014 ª2014 Elsevier Inc.that most of the DORGFP+ NF200+ neurons (62%) in fact
express TrkC (Figures 2A and 2B; Table S1). To characterize
these neurons further and identify proprioceptors, we crossed
Figure 2. DOR-Expressing Myelinated DRG
Neurons Express the Markers of Ab Low-
Threshold Mechanoreceptors TrkC and Ret
(A) TrkC is expressed by about 62% of NF200+
DORGFP+ DRG neurons. Arrows indicate cells
where costaining occurs.
(B) Quantification of (A) and (C)–(I).
(C) Proprioceptors, identified by the coexpression
of parvalbumin and Runx3, do not express
DORGFP. Note that some DORGFP+ neurons
individually express either parvalbumin or Runx3.
(D) Approximately 70% of DORGFP+ TrkC+ neu-
rons coexpress Ret (arrows) indicating that these
neurons are probably myelinated cutaneous
mechanoreceptors, including Ab LTMRs.
(E) About 40% of large-diameter myelinated
(NF200+) DORGFP+ neurons (arrows) and
almost all small-diameter DORGFP+ neurons
express Ret.
(F) Approximately 36% of NF200+ DORGFP+
neurons express CGRP (arrows).
(G) Large-diameter DORGFP+ DRG neurons do
not express the noxious heat sensor TRPV1. A
very small number of small-diameter neurons
coexpress DOR and TRPV1 (arrows).
(H) Large-diameter DORGFP+ neurons that ex-
press CGRP also immunostain for the nociceptor
marker TrkA (arrows).
(I) Almost all large-diameter DORGFP+ neurons
express either TrkC or TrkA.
(J) Molecular identity of myelinated (NF200+)
DORGFP+ neuron subpopulations.
Data are represented as means ± SEM. Scale bars
represent 50 mm.
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rescent protein is expressed by parvalbumin+ DRG neurons.
Figure 2C shows that DORGFP+ neurons do not include propri-
oceptors, marked by the coexpression of parvalbumin and the
transcription factor Runx3 (de Nooij et al., 2013) (Figures 2B
and 2C; Table S1). Rather, we found that many DORGFP+
TrkC+ DRG neurons coexpress Ret, indicating that they are
probably cutaneous mechanoreceptors, including Ab LTMRs
(Figures 2B and 2D–2E; Table S1) (Bourane et al., 2009; Fu¨nf-
schilling et al., 2004; Luo et al., 2009; Senzaki et al., 2010).
We also determined the identity of the remaining 36% of
DORGFP+ NF200+ neurons. This population coexpresses TrkA
and the neuropeptide CGRP, but not TRPV1 (Figures 2B and
2F–2H; Table S1), indicating that they correspond to a particular
class of capsaicin-insensitive A nociceptors. Finally, we did notNeuron 81, 1312–1327observe any DORGFP+ NF200+ neurons
that express the D-hair marker TrkB (Fig-
ures 2B and S2B; Table S1).
Based on this anatomical analysis,
we conclude that DORGFP+ myelinated
DRG neurons are remarkably more het-
erogeneous than previously thought and
segregate into two functionally distinct
classes: a TrkA+ CGRP+ nociceptive
population (36%) and a TrkC+ and/or
Ret+ population of cutaneous mechanoreceptors, which prob-
ably includes Ab LTMRs (62%) (Figure 2J).
MOR Is Expressed by Myelinated Nociceptors and
Colocalizes with DOR in CGRP+ NF200+ DRG Neurons
Although MOR agonists regulate neurotransmitter release from
both C and A nociceptors (Heinke et al., 2011), the precise mo-
lecular identity of the myelinated afferents that express MOR
has so far remained elusive. Here we used an anti-MOR antibody
with demonstrated specificity in mice null for MOR expression
(Scherrer et al., 2009) to characterize these cells. We found
that almost all NF200+ MOR+ neurons express CGRP (99%)
but very rarely TrkC (3%), Ret (5%), or TrkB (0%) (Figures
3A–3G; Table S2). About 8% of NF200+ MOR+ neurons also ex-
press TRPV1. Because of antibody incompatibility, we could not, March 19, 2014 ª2014 Elsevier Inc. 1315
Figure 3. Myelinated DRG Neurons that
Express MOR Coexpress CGRP, but Not
Markers of Ab Low-Threshold Mechano-
receptors
(A) Virtually all MOR+ myelinated neurons
(NF200+) express CGRP (arrows indicate NF200+
MOR+ neurons), indicating that these neurons are
TrkA+ nociceptors (see Figure S2C).
(B) NF200+MOR+ neurons (arrows) rarely express
TrkC.
(C) The great majority of NF200+ MOR+ neurons
express neither Ret nor TrkC (see B), indicating
that they are neither proprioceptors nor Ab
LTMRs.
(D) A small subpopulation of NF200+ MOR+ neu-
rons also expresses TRPV1 (arrows).
(E) MOR+ neurons do not express the D-hair
receptor marker TrkB.
(F) Quantification of (A)–(E).
(G) Molecular identity of myelinated (NF200+)
MOR+ neuron subpopulations.
Data are represented asmeans ± SEM. Scale bars
represent 50 mm.
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Nevertheless, since 95% of CGRP+ DRG neurons belong to
the TrkA+ population of nociceptors in rodents (Figure S2C),
we conclude that all NF200+ MOR+ DRG neurons are peptider-
gic A nociceptors, which distinguishes the MOR+ population of
NF200+ DRG neurons from those that express DOR.
To test this hypothesis further, we took advantage of the char-
acteristic anatomy of Ab LTMRs. Some Ab LTMRs, unlike any
other DRG neurons, project not only to the spinal cord dorsal
horn, but also to the dorsal column nuclei (DCN) (Giuffrida and
Rustioni, 1992), brainstem regions critical for integration of touch
information. We stereotaxically microinjected a retrograde
tracer, the B fragment of cholera toxin (CTB), into the DCN of
mice. This protocol labeled Ab LTMR cell bodies in lumbar
DRGs, which we then coimmunostained for DORGFP and1316 Neuron 81, 1312–1327, March 19, 2014 ª2014 Elsevier Inc.MOR (Figure 4A). We found that among
294 CTB+ DRG neurons, 53 expressed
DORGFP (21%). By contrast, we never
observed CTB+ MOR+ cells, which is
consistent with our contention that only
DOR, but not MOR, is expressed by Ab
LTMRs.
We next investigated the identity of the
DRG cells that coexpress DOR andMOR.
Previous studies provided biochemical
and behavioral evidence that DOR-MOR
functional interactions occur in neurons
of the pain pathway (Costantino et al.,
2012) but to date failed to identify the
sensory neurons in which these interac-
tions might take place (although see He
et al., 2011;Wang et al., 2010). Aswe pre-
viously reported (Scherrer et al., 2009),
the incidence of coexpression of these
two opioid receptors in all DRG neuronsis, in fact, low (less than 5%). However, our analysis now estab-
lishes that most DORGFP+ MOR+ DRG neurons express NF200
(88%), corresponding to 6% of all myelinated DRG neurons
(Figures 4A–4C). About one-third of NF200+ DORGFP+ or
NF200+ MOR+ express the other opioid receptor, while coex-
pression in NF200 neurons is very rare (Tables S1 and S2).
Moreover, all the NF200+ DORGFP+ MOR+ neurons belong
to the CGRP+ class of A nociceptors, and the two receptors
are colocalized at the plasma membrane in these cells (Figures
4D and 4E).
To complete our analysis, we next examined small-diameter
unmyelinated (NF200) DRG neurons and tested whether DOR
or MOR are expressed by a population of C LTMRs that express
tyrosine hydroxylase (TH) (Li et al., 2011). We found that DOR+
and MOR+ unmyelinated DRG neurons are predominantly
Figure 4. DOR and MOR Are Colocalized at
the Plasma Membrane of CGRP+ A Noci-
ceptors
(A) Stereotaxic injection of the B fragment of
cholera toxin (CTB) into the dorsal column nuclei
(DCN) labels Ab LTMR cell bodies in lumbar DRGs.
Only DORGFP+ DRG neurons display CTB
immunoreactivity (22.9% ± 2.9%), while MOR+
(0.0% ± 0.0%) and DORGFP+ MOR+ cells do not
(n = 294 CTB+ cells).
(B) DORGFP and MOR are expressed by largely
nonoverlapping populations of DRG neurons.
Some NF200+ neurons express only DOR (white
arrowhead) or MOR (black arrowhead); a third
population coexpresses both receptors (arrow).
(C) Quantification of (B) shows that 87.8% ± 3.9%
of the DRG neurons that coexpress DOR andMOR
are NF200+ (bar graph) and that 6.2%± 1.1%of all
NF200+ DRG neurons coexpress both receptors
(pie chart) (n = 1,091). DOR predominates in
NF200+ neurons (67.3%± 4.3%), MOR in NF200
neurons (79.8% ± 1.9%) (bar graphs).
(D) DORGFP and MOR are coexpressed at
the plasma membrane of large-diameter CGRP+
DRG neurons, which are most often mechanono-
ciceptors (arrow) (Lawson et al., 2008). White
arrowhead points to a large-diameter DORGFP+
CGRP MOR DRG neuron that probably
belongs to the TrkC+ population described in
Figure 1. Black arrowhead illustrates that all large-
diameter MOR+ DRG neurons, and the vast
majority of MOR+ small-diameter cells, coexpress
CGRP.
(E) All DORGFP+ MOR+ large-diameter DRG
neurons coexpress CGRP (100.0% ± 0.0%) and
this population corresponds to 43.3%±7.7%of all
CGRP+ large-diameter DRG neurons (n = 229).
Data are represented as means ± SEM. Scale bars
represent 50 mm.
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TRPV1+ thermonociceptors, respectively, but not TH+ C LTMRs
(Figure S3).
DOR+ Myelinated DRG Neurons Innervate Merkel Cells,
Hair Follicles, and Meissner Corpuscles,
Mechanosensory Organs in the Skin
To clarify the identity of NF200+ DRGneurons that express DOR,
we next analyzed the morphology of the peripheral terminals
of DORGFP-expressing DRG neurons using a whole-mount
cleared skin preparation.
We focused on three distinct skin structures that are major
contributors to cutaneous mechanosensation: Merkel cells,
Meissner corpuscles, and hair follicles. We first immuno-
stained hairy skin of the back of DORGFP mice with an anti-Neuron 81, 1312–1327body against cytokeratin 8 (CK8) and
observed the characteristic distribution
of Merkel cells in touch domes associ-
ated with guard hairs. Furthermore, as
illustrated in Figures 5A, 5C, and S4A,
we found that the majority of Merkelcells are innervated by DORGFP+ NF200+ axons that termi-
nate as flattened disks surrounding the base of Merkel cells.
This anatomical organization is characteristic of the Merkel
cell-neurite complex and establishes that DOR is expressed
by slowly adapting I (SAI) Ab LTMRs that detect light skin
indentation.
We next examined cutaneous mechanosensory organs inner-
vated by rapidly adapting (RA) Ab LTMRs, which include Meiss-
ner corpuscle afferents, and hair follicle longitudinal lanceolate
endings. Recent studies demonstrated that Ret expression in
large-diameter DRG neurons early during development marks
these RA Ab LTMRs (Bourane et al., 2009; Luo et al., 2009).
Consistent with our demonstration of Ret and DORGFP
coexpression in large-diameter DRG neurons (Figure 2), we
found that some DORGFP+ NF200+ axons innervate Meissner, March 19, 2014 ª2014 Elsevier Inc. 1317
Figure 5. The Terminals of DORGFP-
Expressing DRG Neurons Form Touch-De-
tecting Mechanosensory Organs in the Skin
(A) Peripheral axons of DORGFP+ DRG neurons
(green, arrowheads) innervate cytokeratin 8
(CK8)-immunoreactive Merkel cells grouped in
touch domes associated with guard hairs (auto-
fluorescent hair shaft, white arrow).
(B) DORGFP+ terminals form circumferential,
but not longitudinal, endings (arrowheads) around
follicles of most pelage hairs, including guard hairs
(arrow, center of the image).
(C) DORGFP+ axons end as NF200+ flattened
disks (arrowheads) surrounding the base ofMerkel
cells (arrows).
(D) DORGFP+ axons that form circumferential
endings around follicles are myelinated (NF200+)
and are distinct from CGRP+ terminals. Innerva-
tion of a guard hair is shown.
(E) DORGFP+ NF200+ axons form Meissner cor-
puscles in the dermal papillae of the mouse
footpad. TheMeissner corpuscles are localized by
immunoreactivity of the glial protein S100 (arrows).
DORGFP+ NF200 axons penetrate further
into the epidermis (white arrowheads), consistent
with their nonpeptidergic MrgprD+ identity. Black
arrowhead indicates the boundary between stra-
tum corneum (autofluorescent dead cells) and
stratum granulosum.
(F)Myelinated DORGFP+ afferents with epidermal-
free nerve endings often coexpress CGRP (arrow-
heads). Circumferential endings around the follicle
of the small caliber hairs (arrow) express DORGFP
and NF200, but not CGRP.
Autofluorescence generates the fluorescence of
the hair shafts (yellow in A, green in B and D).
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Delta Opioid Receptors and Mechanosensory Neuronscorpuscles, visualized with S100 glial protein immunostaining in
dermal papillae of the footpad (Figure 5E).
We then analyzed the innervation of hair follicles by
DORGFP+ afferents. Strikingly, DORGFP+ NF200+ axons
formed circumferential endings around follicles of the great
majority of guard and smaller pelage hairs but very rarely lon-
gitudinal lanceolate endings (Figures 5B, 5D, and S4A–S4C).
The physiological correlate of circumferential endings is still
unclear; however, their association with hair follicles suggests
a function in mechanosensation. Because DORGFP+ terminals
that innervate hair follicles are distinct from CGRP+ circumfer-
ential endings (Figures 5D, 5F, and S4D), we propose that the
DORGFP+ TrkC+ DRG neurons, which often coexpress Ret,
form circumferential endings and that DOR represents a1318 Neuron 81, 1312–1327, March 19, 2014 ª2014 Elsevier Inc.marker of this poorly characterized pop-
ulation of DRG neurons.
Finally, we observed that numerous
DORGFP+ axons terminate as free nerve
endings in the skin, a morphology that
is characteristic of nociceptors (Figures
5F and S4E). Based on the typical
morphology of the DORGFP+ NF200
axons that extend to the stratum granulo-sum (Zylka et al., 2005), we suggest that these correspond to the
peripheral terminals of DORGFP+ MrgprD+ C mechanocicep-
tors (Figures 5E, S4D, and S4E). We presume that the NF200+
DORGFP+ CGRP+ free nerve endings arise from the population
of TrkA+ DORGFP+ myelinated nociceptors that coexpress
MOR (Figures 5F and S4E).
DORGFP+ Myelinated Afferents Respond to Innocuous
and Noxious Mechanical Stimuli
Our neuroanatomical analysis demonstrating that Meissner
corpuscle andMerkel cell afferents express DORGFP suggested
that these DORGFP+ DRG neurons are Ab LTMRs. How-
ever, neither the physiological properties nor the mechanosen-
sitivity of other NF200+ DORGFP+ DRG neurons forming
Figure 6. DORGFP-Expressing DRGNeurons Are Mechanosensitive
and Include High- and Low-Threshold Ad Mechanonociceptors
(A) The conduction velocity (CV, 6.6 m/s), broad action potential (bottom left),
high mechanical threshold (10.5 mN, bottom right), and activity-induced
hyperpolarization of the DORGFP+ neuron (green; red: neurobiotin) are char-
acteristics of high-threshold Ad mechanonociceptors.
(B) In comparison to (A), the DORGFP+ Ad fiber recorded exhibits a relatively
narrow action potential and low mechanical threshold (0.07 mN, similar to
LTMRs), indicating that this myelinated nociceptor might also participate in
touch sensation.
(C) Conduction velocity (7.3m/s ± 0.3m/s) andmechanical threshold (1.5mN±
0.7 mN) of 20 DORGFP+ DRG neurons show that most neurons that project to
the trunk skin are low-threshold Ad mechanonociceptors (see example in B).
These cells (blue symbols in right panel) generally have large receptive fields
composed of multiple isolated spots, while the other, comparatively high-
threshold, population of DORGFP+ mechanonociceptors (red; see example
in A) tends to have smaller receptive fields composed of a single spot.
Data are represented as means ± SEM.
Neuron
Delta Opioid Receptors and Mechanosensory Neuronscircumferential or free nerve endings are established. To address
this question, we used a largely intact somatosensory system
preparation and characterized 20 randomly selected large-diam-
eter DORGFP+ DRG neurons. These neurons had conduction
velocities (CVs) between 5.4 and 10.7 m/s and relatively broad
somal action potentials, with inflections on the falling phase of
the spike, a property of Ad nociceptors (Koerber and Woodbury,
2002; Lawson, 2002) (Figure 6). Importantly, all 20 of these
DORGFP+ neurons responded to mechanical stimulation. We
further tested nine of these 20 cells for heat sensitivity and found
that, in contrast, only one cell responded to noxious heat and did
so weakly. DORGFP+ Ad fibers are thus AM mechanonocicep-
tors and probably do not contribute to thermosensation.
Furthermore, the DORGFP+ Ad nociceptors were not uniform,
but rather consisted of at least two distinct populations. One
population included cells with broad somal spikes, high me-
chanical threshold (including cells responding only to noxious
stimuli >10 mN), single spot-like small receptive fields (RFs),
and pronounced long-lasting activity-induced hyperpolarization
(Figures 6A and 6C). These features are characteristic of myelin-
ated high-threshold mechanonociceptors that project to lamina
I-IIo and V of the dorsal horn (Woodbury and Koerber, 2003).
The second, larger population of DORGFP+ Ad nociceptors
comprised cells with relatively low mechanical thresholds, from
0.07 to 0.7 mN, narrower action potentials, and large RFs
composed of multiple isolated spots (Figures 6B and 6C). These
afferents probably correspond to a population of myelinated
mechanoreceptors that project widely from spinal laminae I
to V (Woodbury and Koerber, 2003). Thus, while the latter
DORGFP+ cells encode stimulus intensity and fire vigorously in
response to noxious mechanical stimuli, which defines them as
nociceptors, these afferents also respond to light touch and
innocuous mechanical force (<5 mN), project to the deep
dorsal horn, and thus might participate in both touch and pain
sensation.
Note that a few DORGFP+ neurons had Ab CVs and very
narrow, uninflected spikes indicating that they were putative
low-threshold mechanoreceptors. We could not identify and
characterize the physiological properties of these DORGFP+
Ab fibers because their axons did not travel out of the intact
dorsal cutaneous nerves and instead were cut during prepara-
tion (see Supplemental Experimental Procedures), but we pre-
sume that they may correspond to DORGFP+ SAI or hair follicle
afferents (Figure 5).
Presynaptic DORs Depress Glutamate Release from
Myelinated Mechanoreceptors onto Laminae III–V
Neurons of the Spinal Dorsal Horn
The dominant action of opioid receptors in the nervous system is
to depress neurotransmission by Gi/o protein bg subunit-medi-
ated modulation of ion channel conductances (Williams et al.,
2001). In sensory neurons, MOR agonists inhibit voltage-gated
calcium channels (VGCCs) to reduce C fiber-derived glutamater-
gic neurotransmission to laminae I–II spinal neurons (Heinke
et al., 2011; Taddese et al., 1995), consistent with MOR expres-
sion in peptidergic C nociceptors that project to superficial
laminae of the dorsal horn. We reasoned that DOR function in
myelinated mechanoreceptors might parallel that characteristicNeuron 81, 1312–1327, March 19, 2014 ª2014 Elsevier Inc. 1319
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examined the effect of the DOR-selective agonist deltorphin II
on glutamatergic neurotransmission between A fibers and spinal
neurons in laminae III–V. Indeed the myelinated afferents that
express DORGFP, including SAI Ab afferents, RA Meissner cor-
puscles Ab afferents (Luo et al., 2009), andmyelinatedmechano-
nociceptors (Woodbury and Koerber, 2003), project to this area
of the spinal cord dorsal horn.
We used spinal cord slices from wild-type mice to test the
presence of DOR at the terminals of myelinated mechanorecep-
tors. We first recorded miniature excitatory postsynaptic cur-
rents (mEPSCs), reflecting spontaneous release of glutamate
from sensory neurons and excitatory interneurons, and found
that deltorphin II (500 nM) altered neither the amplitude nor
the frequency of mEPSCs (Figure 7A). We therefore took a
different approach and recorded EPSCs evoked by stimulation
of the dorsal root at an intensity that triggers glutamate release
from Ab fibers. We used a paired-pulse protocol to examine
deltorphin II’s presynaptic effects on monosynaptic eEPSCs.
We observed that deltorphin II significantly reduced the peak
amplitude of the first eEPSC by 56% in 10 of the 17 recorded
cells (i.e., 10 responsive neurons in which deltorphin II reduced
peak amplitude by at least 10%; Figures 7B–7D, 7G, and 7H).
This effect was reversible with wash (Figures 7B and 7C). The
ratio of the peak amplitude of the second eEPSC over the
first is generally related to the probability of neurotransmitter
release. We found that deltorphin II significantly increased
the paired-pulse ratio in responsive cells (32%; Figures 7D,
7G, and 7I), consistent with deltorphin II reducing glutamate
release from Ab fibers. To test for a possible contribution of
DOR expressed by the postsynaptic neuron under study, we in-
terrupted G protein activation in the recorded cells by adding
GDP-bS to the pipette solution. We again observed a deltorphin
II-induced decrease in first eEPSC peak amplitude and an
increase in paired-pulse ratio in a similar proportion of spinal
neurons (8 of the 14 recorded cells), indicating that deltorphin
II’s effect does not require postsynaptic activation of G proteins
(Figures 7E and 7G–7I). Importantly, application of the selective
DOR antagonist naltrindole blocked the deltorphin II effect.
Thus, in the presence of naltrindole, deltorphin II altered neither
the first peak amplitude nor the paired-pulse ratio in any of the
9 recorded cells (Figures 7F–7I), while naltrindole alone had no
effect (Figure S5). Taken together, our findings support the
conclusion that a presynaptic activation of DORs on the central
terminals of Ab fibers underlies deltorphin II’s action and that
DOR functions as a regulator of innocuous mechanical input
to the spinal cord.
DOR Activation Inhibits VGCCs in Myelinated
Mechanoreceptors
We next investigated the molecular mechanism by which DOR
modulates glutamate release from myelinated mechanorecep-
tors using DRG primary culture from DORGFP mice. Figures
8A and S6 show that the neurochemistry of DORGFP+-cultured
cells corresponds to what we observed in DRG sections: most
large-diameter DORGFP+ neurons coexpressed NF200 and
TrkC (Figure 8A), and the great majority of small-diameter
NF200 DORGFP+ neurons bound IB4 (Figure S6).1320 Neuron 81, 1312–1327, March 19, 2014 ª2014 Elsevier Inc.To determine whether DOR activation by deltorphin II affects
VGCC function in myelinated mechanoreceptors, we recorded
voltage-activated calcium currents in large-diameter DORGFP+
neurons (Figure 8B). Figures 8C–8E illustrate that deltorphin II
(500 nM) strongly inhibited VGCCs in all DORGFP+ cells re-
corded, with peak amplitude decreased by 38% compared
to control. Furthermore, current rise time was significantly
increased by deltorphin II (116% of control) (Figures 8C–8E).
In DORGFP-negative large-diameter neurons, deltorphin II had
no effect on current amplitude or rise time. We next used a
DRG primary culture from wild-type mice to test whether deltor-
phin II also inhibits VGCCs in large-diameter neurons in this
preparation. We labeled cultured neurons with IB4-biotin and
streptavidin-Alexa Fluor 555 and recorded deltorphin II effects
in a total of 43 wild-type DRG neurons (Figure 8F). Deltorphin II
(500 nM) inhibited VGCCs in 2 of 10 large-diameter DRG neu-
rons, in 2 of 23 IB4+ small-diameter DRG neurons, and in 1 of
11 IB4 small-diameter DRG neurons (Figures 8G and 8H).
When a high-resistance seal could be maintained, we applied
the MOR agonist DAMGO (500 nM) after deltorphin II and
wash. DAMGO inhibited VGCCs in 4 of 7 IB4 small-diameter
DRG neurons, in 5 of 17 IB4+ small-diameter DRG neurons,
and in none of the 5 large-diameter DRG neurons tested (Figures
8G and 8H). Thus, small-diameter neurons frequently responded
to DAMGO (9/24, 38%) but rarely to deltorphin II (3/34, 9%). This
distinction was evenmore pronouncedwhen considering specif-
ically the IB4 subpopulation that comprises peptidergic C no-
ciceptors. Deltorphin II-responding neurons represent a discrete
population of DRG neurons, most of which have large-diameter
cell bodies, consistent with the idea that DOR regulates neuro-
transmitter release from myelinated mechanoreceptors. Only 1
cell out of 29, an IB4 small-diameter DRG neuron, responded
to both drugs.
Taken together, our histological and electrophysiological
results in DORGFP and wild-type mice support a model of the
functional organization of the opioid system in primary afferent
sensory neurons in which DOR and MOR engage common
molecular mechanisms to regulate neurotransmitter release
from functionally distinct primary afferent DRG neurons. The
product of this segregated opioid receptor organization is a mo-
dality-specific regulation of somatosensation.
DISCUSSION
DOR Expression Pattern in DRG and CNS
Central to the understanding of how opioids influence somato-
sensation is an analysis of the distribution profile of opioid recep-
tors in DRG neurons. Here we localized DOR in wild-type mouse
tissues using in situ hybridization, radioligand binding, calcium
current inhibition in DRG neurons, and inhibition of neurotrans-
mitter release by Ab fibers in spinal cord slices. The results
clearly indicate that, as we proposed based on the analysis of
DORGFP knockin mice (Scherrer et al., 2009), DOR is predomi-
nantly expressed by large-diameter myelinated DRG neurons,
as well as by a subpopulation of IB4-binding nonpeptidergic
unmyelinated nociceptors, but very rarely by SP+ unmyelinated
nociceptors. Importantly, our conclusions are consistent with
previous studies performed in wild-type mice and rats that
Figure 7. Presynaptic DORs Depress Ab Fiber Input to Laminae III–V Spinal Neurons
(A) Voltage-clamp recordings of laminae III–V neurons in spinal cord slices from wild-type mice show that the DOR agonist deltorphin II (500 nM) did not
significantly change miniature EPSC (mEPSC) frequency or amplitude (n = 15).
(B) Example of EPSCs evoked in a lamina III spinal neuron by stimulation of monosynaptically connected Ab fibers using a paired-pulse protocol. Deltorphin II
(500 nM) depressed EPSC peak amplitude and altered the ratio between the amplitudes of the second and first peaks.
(C) Time course of the deltorphin II inhibitory effect on EPSC peak amplitudes.
(D) Deltorphin II (500 nM) significantly reduced the first peak amplitude and increased the paired-pulse ratio in 10 of the 17 recorded cells (responsive neurons).
(E) GDPbS (1 mM in internal solution) did not block deltorphin II’s effect (8/14 recorded neurons with GDPbS responded to deltorphin II, a proportion similar to D),
which confirms a presynaptic mechanism of action.
(F) The DOR antagonist naltrindole (1 mM) prevented deltorphin II’s effect in all recorded neurons (n = 9).
(G) Summary showing all recorded cells. Red, deltorphin II responsive neurons; black, nonresponsive neurons; blue, deltorphin II responsive neurons with
GDPbS; brown, nonresponsive neurons with GDPbS; green, cells recorded in the presence of naltrindole. The dotted line represents the threshold value (10%)
of percent change of first peak amplitude at which cells were considered responsive.
(H) Average deltorphin II effect on first peak amplitude. Color code as in (G).
(I) Average deltorphin II effect on paired-pulse ratio. Color code as in (G).
Data are represented as means ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001.
Neuron
Delta Opioid Receptors and Mechanosensory Neurons
Neuron 81, 1312–1327, March 19, 2014 ª2014 Elsevier Inc. 1321
Figure 8. DOR-Mediated Inhibition of Voltage-Gated Calcium Channels in Cultured Large-Diameter DRG Neurons and Functional Organiza-
tion of DOR and MOR in Cutaneous Somatosensory Neurons
(A) Large-diameter NF200+ DORGFP+ cells express TrkC in primary DRG culture (arrows).
(B) DOR-expressing large-diameter DRG neurons (brightfield image at right) are identified by direct visualization of DORGFP fluorescence (arrow, left image).
(C) Deltorphin II (500 nM) reduces amplitude and increases rise time of voltage-activated calcium currents in DORGFP+ DRG neurons, but not in DORGFPDRG
neurons.
(D) Average effect of deltorphin II on current amplitude in DORGFP+ (n = 11) and DORGFP large-diameter neurons (n = 7).
(legend continued on next page)
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observed over large ganglion cells immunopositive for neurofila-
ment 200’’ (Mennicken et al., 2003) and that ‘‘among the neurons
which highly expressed mu-, delta- or kappa-OPR mRNA, PPTA
mRNA was not expressed in about 58%, 95%, or 24% of those
neurons, respectively’’ (Minami et al., 1995).
On the other hand conclusions derived from use of the anti-
DOR3-17 antibody disagree with these earlier findings, and with
ours. In those studies, strong DOR3-17-ir is found in small-diam-
eter DRG neurons and colocalized with SP (Bao et al., 2003;
Guan et al., 2005). The mismatch is even more striking in the spi-
nal cord, where DOR3-17-ir was found to be restricted to the ter-
minals of peptidergic afferents in laminae I–II. By contrast, DOR
ligand binding in wild-type mice, as well as DORGFP fluores-
cence, are observed throughout the spinal gray matter, consis-
tent with in situ hybridization and electrophysiological recordings
in spinal cord from rats that established the existence of DOR-
expressing spinal neurons (Cahill et al., 2001; Eckert et al.,
2001; Mennicken et al., 2003). Because DOR3-17-ir is intact in
two strains of Oprd1 knockout mice, we proposed that anti-
DOR3-17 antibody recognizes a different molecule and misrepre-
sents DOR distribution (Scherrer et al., 2009). This statement
applies to several other commercial antibodies that we have
evaluated (Scherrer et al., 2009), including an anti-DOR2-18
antibody (Wang et al., 2010) that recognizes an unidentified
surface molecule expressed mostly in large-diameter, Runx3+
DORGFP- DRG neurons (Figure S7). To explain the discrepancy
between the DOR expression pattern obtained with DORGFP
mice and with the anti-DOR3-17 antibody, Wang et al. proposed
that the GFP tag altered subcellular localization and trafficking of
the receptor in DORGFP mouse. Note that here DORGFP
knockin mice were used to identify DOR-expressing DRG neu-
rons, not to study receptor distribution inside the cell. Because
a variety of experimental conditions differ between DORGFP
expression in the reporter mouse and the heterologous overex-
pression of distinct DOR-GFP fusion constructs in in vitro
systems, it is unclear that differences in trafficking reported by
Wang et al. are relevant to the DORGFP receptor in vivo. In
fact, the agreement between the DORGFP fluorescence pattern
and the DOR radioligand binding pattern in wild-type mice, both
of which notably arise from labeling of receptors trafficked to(E) Average effect of deltorphin II on current rise time in DORGFP+ (n = 11) and DO
***p < 0.001.
(F) Labeling of IB4+ neurons in DRG culture from a wild-type mouse.
(G) In the DRG culture shown in (F), deltorphin II (500 nM) predominantly inhibi
dominantly inhibited VGCCs in small-diameter (<40 pF) IB4- neurons.
(H) Occurrence of deltorphin II- and DAMGO-mediated inhibition of VGCCs in 44
out of 29 tested for deltorphin II- and DAMGO-responsiveness (*) showed VGCC
(I) Schematic of the functional organization of DOR and MOR in cutaneous som
myelinated mechanoreceptors, which include SAI and RA Ab LTMRs that form th
DOR is also expressed bymyelinated mechanonociceptors (AM), some of which a
The axons derived from DOR+ TrkC+ AM Ad mechanonociceptors, which often c
this remains speculative. Additionally, DOR is expressed by Ret+ MrgprD+ C
contrast, MOR is predominantly expressed by capsaicin- and heat-sensitive TRP
and regulates heat pain perception. Colocalization of DOR and MOR occurs in m
threshold Ad or Abmechanonociceptors. Most TH+ C LTMRs, TrkB+ D-hair mech
follicles do not appear to express DOR or MOR.
Data are represented as means ± SEM.cellular compartments such as dendrites and axon terminals,
together with the intact antinociceptive and prolocomotive prop-
erties of DOR agonists in DORGFP mice (Pradhan et al., 2009;
Scherrer et al., 2006), strongly argues that the DORGFP traffics
and functions as does the native DOR.
Surprisingly, in situ hybridization and electrophysiological ex-
periments performed by Wang et al. also suggested that DOR
was expressed by the majority of small-diameter neurons,
including peptidergic C nociceptors (Wang et al., 2010). It is
possible that inadequate in situ hybridization probes and/or
excessive probe concentration or reaction time led to nonspe-
cific labeling of DOR-negative DRG neurons. As for the electro-
physiological experiments, seemingly excessive concentrations
of DOR agonists (10 mM of deltorphin II or SNC80) were used for
ligands with KD in the nanomolar range. At these high concen-
trations, off-target effects cannot be excluded, in particular
cross-activation of MOR by these ligands, a finding already
documented using Oprd1 and Oprm1 knockout mice (Gendron
et al., 2007; Scherrer et al., 2004). Note also that Wang et al.
omitted to consider the possibility that convergent inputs from
distinct DOR+ and MOR+ fibers can modulate neurotransmitter
release onto a given spinal neuron, without requiring coexpres-
sion of the two receptors in the same primary afferent neurons.
Similarly, data on the inhibition of spinal SP release by intrathecal
DOR agonists (for example, Beaudry et al., 2011; Kouchek et al.,
2013) should be interpreted carefully, because both SP and DOR
are expressed, and possibly coexpressed, by numerous spinal
neurons, thus preventing definitive conclusions to be drawn
regarding DOR and SP coexpression in DRG neurons. By
contrast, CGRP is restricted to primary afferent terminals in the
dorsal horn, and our data showing DOR andCGRP coexpression
in large-diameter NF200+ DRG neurons, and DOR-mediated in-
hibition of VGCCs in these cells, are consistent with the idea that
DOR agonists can reduce CGRP release (Overland et al., 2009)
and further suggest this effect results mostly from an action on
myelinated nociceptors.
Functional Organization of Opioid Receptors in Primary
Afferent Somatosensory Neurons
We showed here that most DORGFP+ NF200+ DRG neurons
coexpress TrkC and/or Ret, which mark several categories ofRGFP large-diameter neurons (n = 7). Results are expressed as mean ± SEM,
ted VGCCs in large-diameter neurons (>40 pF), while DAMGO (500 nM) pre-
randomly selected neurons in DRG cultures from wild-type mice. Only one cell
inhibition by both drugs.
atosensory neurons. DOR is expressed by populations of TrkC+ and/or Ret+
e Merkel cell-neurite complex (yellow) and Meissner corpuscles, respectively.
re Ad fibers, have low threshold, and respond to innocuous mechanical stimuli.
oexpress Ret, may form circumferential endings around hair follicle, although
mechanonociceptors (CM) that innervate epidermal stratum granulosum. By
V1+ C nociceptors (CH) (many of which are visceral, not cutaneous, afferents)
yelinated TrkA- and CGRP-expressing neurons, which are presumptive high-
anoreceptors, and Ret+ Ab LTMRs that form longitudinal endings around hair
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ling et al., 2004; Luo et al., 2009; Senzaki et al., 2010) (Figure 8I).
In retrograde labeling experiments, we found that many myelin-
ated DORGFP+ neurons project to the dorsal column nuclei.
Analysis of sensory neuron terminals in the skin demonstrated
that DORGFP+ DRG neurons innervate hair follicles, Merkel
cells, and Meissner corpuscles, forming mechanosensory
organs essential for touch. Recordings from DORGFP+ DRG
neurons further showed that DOR is expressed by myelinated
mechanonociceptors, including some with mechanical thresh-
olds in the innocuous range. Electrophysiological experiments
in spinal cord slices also established that DOR is present on
the central terminals of Ab fibers. Altogether, these data indicate
that DOR+ DRG neurons are mechanoreceptors and include
populations of low-threshold afferents that generate touch
sensation (Figure 8I).
In sharp contrast with DOR+ DRG neurons, we found that the
majority of MOR+ DRG neurons display molecular and anatom-
ical features characteristic of NGF-dependent peptidergic noci-
ceptors (lack of expression of Ret, TrkC, and TrkB; no projection
to the DCN; coexpression of CGRP and TRPV1). Our analysis in
DRG agrees with the fact that MOR agonists reduce synaptic
transmission between C and Ad nociceptors and superficial dor-
sal horn neurons (Heinke et al., 2011). Furthermore, morphine al-
ters neither responses of gracile nucleus neurons evoked by Ab
fiber stimulation or brushing of the receptive field (Suzuki and
Dickenson, 2002), touch-evoked Fos expression in the dorsal
horn (Catheline et al., 2001), nor dynamic allodynia induced by
strychnine-mediated disinhibition of dorsal horn circuits (Mirau-
court et al., 2009). We propose, therefore, that MOR regulates
neurotransmitter release from cutaneous nociceptive peptider-
gic TRPV1+ afferents that are heat sensitive and mechanically
insensitive (Lawsonet al., 2008) and, perhaps of particular clinical
relevance, from TRPV1+ visceral afferents that signal injuries to
deep tissues (e.g., postsurgical pain) (Figure 8I). Note, however,
that MOR+ NF200+ DRG neurons might include some Ab noci-
ceptive fibers (Lawson, 2002) or Ab LTMRs that do not project
to the DCN. In our electrophysiological experiments in cultured
DRG neurons from wild-type mouse, we found that DAMGO
had no effect on VGCCs in the five large-diameter DRG neurons
tested (Figure 8). This result is consistent with the idea that MOR
is expressed by a relatively small population of NF200+ neurons
(about 20%) (Figures 3 and 4) and suggests that blind recordings
frommany more DRG neurons would be necessary to determine
precisely the proportion of myelinated neurons that express
MOR. Note also that the DRG culturemight not be fully represen-
tative of the neuronal diversity and proportions found in vivo
because some neurons might be more sensitive than others to
the dissociation procedure. Such factorsmight explain the subtle
differences between electrophysiological results in DRG culture
and those from our histological analysis.
Since DOR inhibits VGCCs in large-diameter NF200+ neurons,
as does MOR in C fibers, our results suggest that in DRG the
specific function of DOR and MOR in the control of somatosen-
sation originates mostly from expression in distinct neuronal
populations. Of course this arrangement does not exclude the
existence of additional cell- or receptor-specific signaling mech-
anisms, such as those that regulate DOR surface expression and1324 Neuron 81, 1312–1327, March 19, 2014 ª2014 Elsevier Inc.functional competence (Hack et al., 2005; Patwardhan et al.,
2005; van Rijn et al., 2012). Note that it is possible to isolate
the main action of intrathecal DOR and MOR agonists against
mechanical and heat pain, respectively, when using low doses
of SNC80 and DAMGO (Scherrer et al., 2009). On the other
hand, it is well established that DOR and MOR agonists can
reduce both mechanical and heat pain (reviewed in Gave´riaux-
Ruff and Kieffer, 2011; Ossipov et al., 2004), especially when
higher doses are used. Future studies will clarify whether this
antinociceptive action across pain modalities results from the
corecruitment of rarer populations of afferents (i.e., heat-sensi-
tive DOR+ and mechanosensitive MOR+), polymodal spinal
and descending control systems, or the combined activation of
multiple opioid receptor types, possibly including multimers.
It is significant that we have identified discrete populations of
neurons that do coexpress both receptors. First, as we reported
previously (Scherrer et al., 2009), about 10% of DOR+ NF200
small-diameter DRG neurons are TRPV1+ peptidergic C noci-
ceptors, all of which express MOR. Second, we now establish
that the vast majority of DOR/MOR-coexpressing DRG neurons
are in fact DRG neurons withmyelinated axons (NF200+) that ex-
press CGRP and TrkA. Analogous to the MrgprA3-expressing
DRG cells that only represent about 4% of DRG neurons but
are entirely responsible for chloroquine-induced pruritus (Liu
et al., 2009), the DOR/MOR-coexpressing cells probably have
a significant and selective function in somatosensation despite
their small number (<5% of all DRG neurons). Because CGRP+
cutaneous A fibers are mostly high-threshold mechanonocicep-
tors (AM class; Koerber and Woodbury, 2002; Lawson et al.,
2008), our results suggest that studies examining the functional
relevance of interactions between DOR andMOR should include
behavioral assays of Ad or Ab fiber-mediated mechanical pain.
Our model (Figure 8I) thus proposes that opportunities for
DOR/MOR interaction in DRG, including DOR/MOR heterodime-
rization, is probably restricted to discrete cell populations, with
the corollary that agents modulating these interactions may be
useful to treat pain disorders resulting from dysfunction of these
particular neurons, with limited side effects.
DOR-Mediated Control of Cutaneous
Mechanosensation
Numerous studies have demonstrated that DOR-selective ago-
nists reducemechanical hypersensitivity induced by nerve or tis-
sue injury in rodents (Gave´riaux-Ruff and Kieffer, 2011). Because
selective activation of DOR has limited utility against acute heat
pain, these results were considered to reflect the prime function
of DOR in the control of chronic, but not acute, pain. In light of
accumulating evidence supporting the existence of peripheral
labeled lines for distinct pain modalities (Basbaum et al., 2009),
we rather propose that it is the preferential association of DOR
with myelinated mechanonociceptors and LTMRs that underlies
the particular analgesic profile of DOR agonists against acute
mechanical pain and chronic mechanical hypersensitivity. A pre-
vious study using mice with a conditional deletion of Oprd1 in
DRG neurons expressing the sodium channel Nav1.8 suggested
that DOR+ unmyelinated nociceptors, rather than NF200+ neu-
rons, were essential for the anti-allodynic effect of DOR agonists
(Gaveriaux-Ruff et al., 2011). However, a fate map analysis has
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Cre mice is, in fact, not restricted to nociceptors but rather is
also observed in several categories of C and A LTMRs (Shields
et al., 2012). As a result, the precise population of DRG neurons
that underlies DOR-mediated anti-allodynia remains to be
identified.
Our demonstration that DOR+ NF200 DRG neurons belong
to the MrgprD+ subset of nonpeptidergic, IB4-binding, Ret+ C
nociceptors (Figures S3E and 8I) agrees with a recent quantita-
tive PCR study that showed that Ret is essential for the normal
expression of Oprd1 in the DRG (Franck et al., 2011) and the
observation that a DOR agonist inhibits GDNF-induced hyperal-
gesia (Joseph and Levine, 2010). MrgprD+ DRG neurons
respond to punctate noxious mechanical stimulation and are
essential for acute mechanical pain, but not persistent injury-
induced mechanical hypersensitivity (Cavanaugh et al., 2009).
Conceivably, these DOR+ C nociceptors underlie the effect of
DOR agonists on basal mechanical thresholds but are unlikely
to mediate their anti-allodynic effects in models of inflammatory
or neuropathic pain.
By contrast, DOR+ myelinated mechanoreceptors emerge as
strong candidate neurons to signal mechanical allodynia. First,
sensory testing in neuropathic pain patients indicates that
large-diameter myelinated fibers, not C fibers, are essential for
mechanical allodynia (Campbell et al., 1988). Second, the sen-
sory modalities encoded by DOR+ myelinated mechanorecep-
tors precisely correspond to the innocuous stimuli that evoke
pain in allodynic patients. Thus, movement of objects across
the skin or light pressure that typically generate pain (dynamic
or static allodynia, respectively), such as is caused by clothing,
are expected to engage DOR+ hair follicle, Meissner corpuscle,
and/or SAI afferents (Figure 8I). These DOR+ afferents could fire
more vigorously in response to light touch after injury, causing
pain. Alternatively, their normal response to innocuous mechan-
ical stimulation could cause pain after injury if central disinhibi-
tion mechanisms are in effect. These two scenarios are not
mutually exclusive, and future studies will investigate the mech-
anisms by which DORs present on the peripheral terminals of
mechanoreceptors may regulate threshold and firing pattern to
contribute to opioid analgesia (Stein and Machelska, 2011).
In summary, our results provide a conceptual framework for
the functional organization of opioid receptors in primary afferent
neurons and the inhibitory mechanisms by which opioids control
mechanosensation. This model provides a cellular basis for a
more rational use of MOR agonists in the clinic and will foster
the design of alternative analgesic strategies, including DOR
targeting, based on the identity of the primary afferents
engaged and the nature of the stimulus causing pain, particularly
for touch-evoked neuropathic pain and movement/pressure-
evoked pain, two major clinical problems.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for further details.
Animals
All procedures were approved by the Stanford, Columbia, or UCSF Institu-
tional Animal Care and Use Committees. See Supplemental Experimental
Procedures for a description of the mice used.Spinal Cord Slice Preparation and Electrophysiology
The lumbar spinal cord of postnatal days 15–22 (P15–P22) C57BL/6 mice was
isolated, and transverse slices with dorsal roots attached were made using a
vibrating microtome. Patch-clamp recording in whole-cell configuration and
voltage-clamp mode at a holding potential of 70 mV was performed at
room temperature (RT) on laminae III–V neurons. EPSCs were evoked
(eEPSCs) by stimulating the dorsal root with a suction electrode (25 to 50 mA
intensity, 0.1 ms duration). eEPSCs with constant latency and no failures dur-
ing a train of 20 stimuli at 50 Hz were considered monosynaptic responses
mediated by Ab fibers. Paired-pulse recordings were obtained by stimulating
the dorsal root continuously at 0.1 Hz.
Primary DRG Culture and Electrophysiology
Lumbar and thoracic DRGs from P21–P42 DORGFP or C57BL/6 wild-type
mice were collected, digested, centrifuged, resuspended in MEM complete
medium, and plated onto Poly-D,L,ornithine hydrobromide-coated coverslips.
Patch-clamp recording in whole-cell configuration was performed 2 to 6 hr
after plating. Cells were classified as small or large based on capacitance
(small < 40 pF < large). Recordings were performed in voltage-clamp mode
with 80 mV holding potential and a 100 or 200 ms depolarization to 10 mV
was used to activate VGCCs before and after perfusion of deltorphin II
(500 nM) or DAMGO (500 nM). Current amplitude and rise time (20%–80%)
were determined using Clampfit software.
Histology
Immunostaining was performed as described previously (Li et al., 2011; Scher-
rer et al., 2009). Briefly, mice were anesthetized and perfused transcardially
with PBS followed by 10% formalin solution. Lumbar DRGs were dissected
and cryoprotected in sucrose solution. Skin was dissected, postfixed in
10% formalin, cryoprotected, and cut at 20 mm or processed for whole-mount
staining. Tissue sections were incubated in blocking solution for 1 hr at RT, pri-
mary antibody overnight at 4C, and secondary antibody for 2 hr at RT. Whole-
mount staining was performed as described by Li et al. (2011). Images were
acquired with a confocal microscope. Methods for in situ hybridization are
described in detail in Supplemental Experimental Procedures. Radioligand
binding experiments have been performed as previously described (Scherrer
et al., 2009).
Largely Intact Somatosensory System Preparation and
Electrophysiology
This preparation has been described previously (Koerber and Woodbury,
2002). Briefly, mice were anesthetized and perfused transcardially with
oxygenated artificial cerebrospinal fluid (aCSF). The spinal cord, thoracic
DRGs, dorsal cutaneous nerve, and trunk skin were dissected in continuity
and pinned out in a recording chamber. DORGFP+ somata were impaled
with micropipettes, and electrical search stimuli were delivered to the intact
dorsal cutaneous nerve through an en passant suction electrode to identify
cells with intact peripheral axons. Peripheral RFswere located with a fine sable
paint brush or blunt glass stylus, and mechanical thresholds were determined
with calibrated von Frey filaments. Thermal sensitivity was tested by applying
heated (52C) aCSF to the RF. Conduction velocity was calculated from spike
latency and the distance between stimulating and recording electrodes.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2014.01.044.
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